UBS Group

UBS Group’s ACELYRIN SLRN Stock Holding History

UBS Group’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$256K	Sell
2024 Q4	$587K	Buy
2024 Q3	$191K	Buy
2024 Q2	$132K	Sell
2024 Q1	$1.69M	Buy
2023 Q4	$13.7K	Buy
2023 Q3	$5.27K	Sell
2023 Q2	$43.5K	Buy